Bria-IMT plus check point inhibitors had a median overall survival which outperformed that of antibody-drug conjugates in HR+ ...

BriaCell stock (TSX:BCT) is positioned to the upside after reporting phase 2 survival data for its Bria-IMT cell therapy with ...

During a live event, Megan Kruse, MD, discussed NCCN guidelines and key therapies for patients with HR-positive metastatic ...

Former Bachelorette star Katie Thurston is sharing a major update on her cancer journey after having to put her treatments on ...

The National Institute for Health and Care Excellence has now approved capivasertib for use on the NHS - we look at who could ...

Breast cancer subtyping is essential for determining appropriate treatment strategies, as each molecular category, luminal A, ...

Even after the removal of breast tissue, it is possible that the cancer may recur in the chest wall or the area where the ...

Thousands with advanced breast cancer could live long lives thanks to a new drug approved on the NHS . Capivasertib, retailed ...

Professor Nicholas Turner, from the Institute of Cancer Research, tells Sky News that capivasertib is a "great success story ...

The incidence of interval breast cancer has increased over a 30-year period while the proportion has remained steady.

A new type of drug for one of the most common kinds of advanced breast cancer is now available on the NHS in England. Some ...